In this episode, we look at why timing changes everything when it comes to stem cells and stroke recovery, comparing what the research shows in acute versus chronic cases.
You'll learn:
- Why researchers study acute and chronic stroke stem cell research as two separate questions
- How mesenchymal stem cells, neural stem cells, and bone marrow mononuclear cells each play a different role
- Why most acute-phase research focuses on safety before benefit
- What a landmark 2-year chronic stroke trial found for motor function and safety
- Why sample sizes in this field remain small compared to drug trials
- What separates a good candidate from someone who should wait
- What a consultation should cover before considering treatment at any stage
Whether you're researching options right after a stroke or exploring what comes months later, this episode breaks down what the science actually supports at each stage.
Blog Link: Stem Cell Therapy for Stroke: Acute vs Chronic Cases
